A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma
Clinical trial NCT01656642 · COMPLETED
Trial details
- NCT number
- NCT01656642
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-13
- Primary completion
- 2020-03-25
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.